We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

$12 M Awarded for New COVID-19 Vaccine Manufacturing Efforts

News   Mar 25, 2020 | Original story from the University of Saskatchewan

 
$12 M Awarded for New COVID-19 Vaccine Manufacturing Efforts

VIDO-InterVac researchers are working on prototype vaccines to combat the new coronavirus outbreak. Credit: David Stobbe for the University of Saskatchewan

 
 
Advertisement
 

RELATED ARTICLES

Mixing COVID-19 Vaccines Increases Side Effects, Preliminary Data Suggests

News

Leaders of the Com-COV study share preliminary findings that suggest combining different COVID-19 vaccines increases the reactogenicity (side effect profile) associated with vaccination.

READ MORE

Machine Learning Predicts Which COVID-19 Patients Will Respond to Treatment

News

Researchers used AI to identify which daily changing clinical parameters best predict intervention responses in critically ill COVID-19 patients.

READ MORE

Severe COVID-19 Alters Gray Matter Volume in the Brain

News

Covid-19 patients who receive oxygen therapy or experience fever show reduced gray matter volume in the frontal-temporal network of the brain, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE